|
1
|
Trousseau A: Phlegmasia alba dolens. Clin
Med Hotel-dieu Paris. 3:654–712. 1865.
|
|
2
|
Key NS, Khorana AA, Kuderer NM, Bohlke K,
Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW,
et al: Venous thromboembolism prophylaxis and treatment in patients
with cancer: ASCO clinical practice guideline update. J Clin Oncol.
38:496–520. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Timp JF, Braekkan SK, Versteeg HH and
Cannegieter SC: Epidemiology of cancer-associated venous
thrombosis. Blood. 122:1712–1723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen AT, Katholing A, Rietbrock S, Bamber
L and Martinez C: Epidemiology of first and recurrent venous
thromboembolism in patients with active cancer. A population-based
cohort study. Thromb Haemost. 117:57–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prandoni P, Lensing AW, Piccioli A,
Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins
MH, Noventa F and Girolami A: Recurrent venous thromboembolism and
bleeding complications during anticoagulant treatment in patients
with cancer and venous thrombosis. Blood. 100:3484–3488. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee AY: Epidemiology and management of
venous thromboembolism in patients with cancer. Thromb Res.
110:167–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prandoni P, Falanga A and Piccioli A:
Cancer and venous thromboembolism. Lancet Oncol. 6:401–410. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cestari DM, Weine DM, Panageas KS, Segal
AZ and DeAngelis LM: Stroke in patients with cancer: Incidence and
etiology. Neurology. 62:2025–2030. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rickles FR: Mechanisms of cancer-induced
thrombosis in cancer. Pathophysiol Haemost Thromb. 35:103–110.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grisold W, Oberndorfer S and Struhal W:
Stroke and cancer: A review. Acta Neurol Scand. 119:1–16. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Graus F, Rogers LR and Posner JB:
Cerebrovascular complications in patients with cancer. Medicine
(Baltimore). 64:16–35. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khorana AA, Francis CW, Culakova E,
Kuderer NM and Lyman GH: Thromboembolism is a leading cause of
death in cancer patients receiving outpatient chemotherapy. J
Thromb Haemost. 5:632–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schwarzbach CJ, Schaefer A, Ebert A, Held
V, Bolognese M, Kablau M, Hennerici MG and Fatar M: Stroke and
cancer: The importance of cancer-associated hypercoagulation as a
possible stroke etiology. Stroke. 43:3029–3034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Varki A: Trousseau's Syndrome: Multiple
definitions and multiple mechanisms. Blood. 110:1723–1729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Noble S and Pasi J: Epidemiology and
pathophysiology of cancer-associated thrombosis. Br J Cancer. 102
(Suppl 1):S2–S9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wun T and White RH: Epidemiology of
cancer-related venous thromboembolism. Best Pract Res Clin
Haematol. 22:9–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takano H, Nakajima K, Nagayoshi Y,
Komazaki H, Suzuki J, Tanabe H, Niimi S, Isonishi S and Okamoto A:
Clinical associations of Trousseau's syndrome associated with
cerebral infarction and ovarian cancer. J Gynecol Oncol.
29:e672018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, He Y and Su Y: Multifocal cerebral
infarction as the first manifestation of occult malignancy: Case
series of Trousseau's syndrome and literature review. Brain Circ.
4:65–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim SG, Hong JM, Kim HY, Lee J, Chung PW,
Park KY, Kim GM, Lee KH, Chung CS and Bang OY: Ischemic stroke in
cancer patients with and without conventional mechanisms: A
multicenter study in Korea. Stroke. 41:798–801. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaturvedi S, Ansell J and Recht L: Should
cerebral ischemic events in cancer patients be considered a
manifestation of hypercoagulability? Stroke. 25:1215–1218. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pinzon R, Drewinko B, Trujillo JM, Guinee
V and Giacco G: Pancreatic carcinoma and Trousseau's syndrome:
Experience at a large cancer center. J Clin Oncol. 4:509–514. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brierley JD, Gospodarowicz MK and
Christian Wittekind C: TNM Classification of Malignant Tumours. 8th
edition. Wiley Publications; Hoboken, NJ: 2016
|
|
23
|
Araki E, Goto A, Kondo T, Noda M, Noto H,
Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K and Yoshioka N:
Japanese clinical practice guideline for diabetes 2019. Diabetol
Int. 11:165–223. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Umemura S, Arima H, Arima S, Asayama K,
Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, et al:
The Japanese society of hypertension guidelines for the management
of hypertension (JSH 2019). Hypertens Res. 42:1235–1481. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lipsy RJ: The National cholesterol
education program adult treatment panel III guidelines. J Manag
Care Pharm. 9 (Suppl 1):S2–S5. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
KDIGO CKD Work Group, : KDIGO 2012
Clinical Practice Guideline for the Evaluation and Management of
Chronic Kidney Disease. Kidney Int. (Suppl 3):1–150. 2013.
|
|
27
|
Gando S, Iba T, Eguchi Y, Ohtomo Y,
Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, et
al: A multicenter, prospective validation of disseminated
intravascular coagulation diagnostic criteria for critically ill
patients: Comparing current criteria. Crit Care Med. 34:625–631.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Puhr R, Heinze G, Nold M, Lusa L and
Geroldinger A: Firth's logistic regression with rare events:
Accurate effect estimates and predictions? Stat Med. 36:2302–2317.
2017.PubMed/NCBI
|
|
29
|
Zaorsky NG, Zhang Y, Tchelebi LT, Mackley
HB, Chinchilli VM and Zacharia BE: Stroke among cancer patients.
Nat Commun. 10:51722019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alloubani A, Nimer R and Samara R:
Relationship between hyperlipidemia, cardiovascular disease and
stroke: A systematic review. Curr Cardiol Rev.
17:e0511211890152021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dardiotis E, Aloizou AM, Markoula S,
Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis
AG, Aschner M, et al: Cancer-associated stroke: Pathophysiology,
detection and management (Review). Int J Oncol. 54:779–796.
2019.PubMed/NCBI
|
|
32
|
Lv J, Yang L, Guo R, Shi Y, Zhang Z and Ye
J: Ox-LDL-induced microRNA-155 promotes autophagy in human
endothelial cells via repressing the Rheb/mTOR pathway. Cell
Physiol Biochem. 43:1436–1448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Awkar N, Amireh S, Rai S, Shaaban H, Guron
G and Maroules M: Association between level of tumor markers and
development of VTE in patients with pancreatic, colorectal and
ovarian Ca: Retrospective case-control study in two community
hospitals. Pathol Oncol Res. 24:283–287. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adam SS, Key NS and Greenberg CS: D-dimer
antigen: Current concepts and future prospects. Blood.
113:2878–2887. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tripodi A: D-Dimer testing in laboratory
practice. Clin Chem. 57:1256–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao L, Zhang S, Gong X and Cui G:
Trousseau syndrome related cerebral infarction: Clinical
manifestations, laboratory findings and radiological features. J
Stroke Cerebrovasc Dis. 29:1048912020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taniguchi T, Kakkar AK, Tuddenham EG,
Williamson RC and Lemoine NR: Enhanced expression of urokinase
receptor induced through the tissue factor-factor VIIa pathway in
human pancreatic cancer. Cancer Res. 58:4461–4467. 1998.PubMed/NCBI
|
|
38
|
Tsushima M, Metoki N, Hagii J, Saito S,
Shiroto H, Yasujima M, Kato T, Kudo N, Toyama Y, Yokono Y, et al:
D-Dimer and C-reactive protein as potential biomarkers for
diagnosis of trousseau's syndrome in patients with cerebral
embolism. J Stroke Cerebrovasc Dis. 29:1045342020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Khorana AA, Kuderer NM, Culakova E, Lyman
GH and Francis CW: Development and validation of a predictive model
for chemotherapy-associated thrombosis. Blood. 111:4902–4907. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mulder FI, Candeloro M, Kamphuisen PW, Di
Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR and van Es N;
CAT-prediction collaborators, : The khorana score for prediction of
venous thromboembolism in cancer patients: A systematic review and
meta-analysis. Haematologica. 104:1277–1287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Donati MB and Lorenzet R: Thrombosis and
cancer: 40 years of research. Thromb Res. 129:348–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ikushima S, Ono R, Fukuda K, Sakayori M,
Awano N and Kondo K: Trousseau's Syndrome: Cancer-associated
thrombosis. Jpn J Clin Oncol. 46:204–208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Noble S and Goa KL: Gemcitabine. A review
of its pharmacology and clinical potential in non-small cell lung
cancer and pancreatic cancer. Drugs. 54:447–472. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
van Hell AJ, Haimovitz-Friedman A, Fuks Z,
Tap WD and Kolesnick R: Gemcitabine kills proliferating endothelial
cells exclusively via acid sphingomyelinase activation. Cell
Signal. 34:86–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sasaki R, Ohya Y, Hayashida S, Maeda Y,
Murahashi S, Kumamoto S, Tsuji A, Shibata H, Kuramoto K, Hayashi H,
et al: A case of Trousseau's syndrome due to intrahepatic
cholangiocarcinoma with an extremely high level of CA19-9. Surg
Case Rep. 6:752020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yamamoto R, Kato S, Takahashi M, Ono S,
Sakurada T, Nagoshi S, Nisikawa K and Yakabi K: Trousseau syndrome
accompanied by cholangiocellular carcinoma: Report of two. J
Saitama Medical University. 40:131–134. 2014.
|
|
47
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nuver J, De Haas EC, Van Zweeden M,
Gietema JA and Meijer C: Vascular damage in testicular cancer
patients: A study on endothelial activation by bleomycin and
cisplatin in vitro. Oncol Rep. 23:247–253. 2010.PubMed/NCBI
|
|
49
|
Walsh-McMonagle D and Green D:
Low-molecular-weight heparin in the management of Trousseau's
syndrome. Cancer. 80:649–655. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yoshida K, Kimura T, Aburakawa Y, Suzuki
Y, Kuroda K and Yahara O: Recurrent ischemic stroke in a patient
with the trousseau syndrome treated with dabigatran. J Stroke
Cerebrovasc Dis. 23:1724–1726. 2014. View Article : Google Scholar : PubMed/NCBI
|
